Aristotle Atlantic Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$13.5M |
| 2 |
Iovance Biotherapeutics
IOVA
|
+$11.6M |
| 3 |
CrowdStrike
CRWD
|
+$10.9M |
| 4 |
Apple
AAPL
|
+$5.92M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$4.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$18.5M |
| 2 |
Qorvo
QRVO
|
+$12.5M |
| 3 |
NVIDIA
NVDA
|
+$11.5M |
| 4 |
Merck
MRK
|
+$4.05M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$1.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.45% |
| 2 | Healthcare | 17.04% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 9.52% |
Similar funds
Aristotle Atlantic Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Aristotle Atlantic Partners held 104 positions worth $1.72B, up 14% from $1.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Aristotle Atlantic Partners deployed $74.4M of net new capital in Q4 2021, opening 5 new positions and adding to 59 existing holdings. Its largest new stake was Synopsys: 40,090 shares worth $14.8M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Teleflex, an estimated $18.5M trimmed.
- Aristotle Atlantic Partners's largest Q4 2021 buy was Synopsys: 40,090 shares worth $14.8M.
- Aristotle Atlantic Partners added most to CrowdStrike in Q4 2021, an estimated $10.9M increase.
- Aristotle Atlantic Partners's biggest Q4 2021 reduction was Teleflex, cutting an estimated $18.5M.
- Aristotle Atlantic Partners fully exited Qorvo in Q4 2021, selling an estimated $12.5M.
- Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.72B portfolio in Q4 2021.
- Aristotle Atlantic Partners opened 5 new positions and closed 3 in Q4 2021.
- Aristotle Atlantic Partners's portfolio value rose 14% quarter-over-quarter to $1.72B.
Based on Aristotle Atlantic Partners's 13F filing for Q4 2021, filed 14 Feb 2022.